Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.23.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share
The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):
For the three months ended
March 31, 2023 March 31, 2022
Net income - basic $ 550  $ 12,494 
Interest on unsecured convertible promissory note 60  232 
Net income - diluted $ 610  $ 12,726 
Weighted average shares outstanding - basic 16,748 15,486
Diluted shares- Stock Options 22 2,232
Diluted shares- Stock Warrants 1,051 222
Unsecured convertible promissory note 240 800
Weighted average shares outstanding - diluted 18,061 18,740
Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation
The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):
For the three months ended
Anti-dilutive securities March 31, 2023 March 31, 2022
Common stock purchase warrants 581 455
Stock Options 870 810
Anti-dilutive securities 1,451 1,265